Skip to main content

and
  1. Article

    Open Access

    Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia

    Predicting the response to medical therapy and subsequently individualizing the treatment to increase efficacy or reduce toxicity has been a longstanding clinical goal. Not least within oncology, where many pa...

    Jacob Nersting, Louise Borst, Kjeld Schmiegelow in Clinical Proteomics (2011)

  2. Article

    Relating genomic variation to drug response in childhood acute lymphoblastic leukemia by multiplexed targeted sequencing

    Agata Wesolowska, Marlene D Dalgaard, Louise Borst, Laurent Gautier in Genome Biology (2010)